Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
15.08.23
/
50%
€0.93
Target price
15.08.24
€6.40
Performance (%)
-45.10%
Price
19:00
€0.51
Summary
This prediction is currently active. Massive losses of -45.10% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 15.08.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sangamo Therapeutics Inc. | -9.686% | -9.686% |
| iShares Core DAX® | -0.683% | 1.890% |
| iShares Nasdaq 100 | 0.335% | 4.631% |
| iShares Nikkei 225® | -1.486% | -2.361% |
| iShares S&P 500 | -0.523% | 2.324% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Truist Financial Co. from $8.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat